Clinical Trials Logo

Infant Colic clinical trials

View clinical trials related to Infant Colic.

Filter by:
  • None
  • Page 1

NCT ID: NCT05271747 Completed - Infant Colic Clinical Trials

Prospective Study to Determine the Factors Influencing Infant Colic

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

Randomized study to determine the effect of a commercialized combination of 2 probiotic strains (Bifidobacterium Longum and Pediococcus pentosaceus) and the impact of feeding type in babies diagnosed with colic under Roma IV criteria when administered for 21 days.

NCT ID: NCT04015089 Recruiting - Infant Colic Clinical Trials

Infant Formula With Partially Hydrolyzed Cow's Milk Protein Versus a Formula With Intact Protein

VEGY-UP
Start date: July 19, 2018
Phase: N/A
Study type: Interventional

Randomized, parallel, double-blind clinical trial, comparing a partially hydrolyzed serum proteins infant formula with a conventional formula with intact protein in healthy infants that suffer from colic

NCT ID: NCT03467334 Completed - Infant Colic Clinical Trials

Infant Colic Treatment With Probiotics

Start date: May 31, 2017
Phase: Phase 2
Study type: Interventional

This study evaluates the efficacy of Bifidobacterium breve CECT7263 and the mixture B. breve CECT7263/Lactobacillus fermentum CECT5716 in the treatment of infant colic. Group 1 will receive B. breve CECT7263 (2x10E8 CFU/day) one dose per day, group 2 will receive B. breve CECT7263 (1x10E8 CFU/day) and L. fermentum CECT5716 (1x10E8 CFU/day) in one dose per day, group 3 (control group) will receive simethicone 20 mg 4 times a day.

NCT ID: NCT02839239 Completed - Infant Colic Clinical Trials

Lactocare Baby Drops in Infants Colic

LACONIC
Start date: December 9, 2016
Phase: N/A
Study type: Interventional

The objective of this study is to determine an efficacy of the combination of L. rhamnosus 19070-2 (FloraActiveTM) and L. reuteri DSM 122460 (FloraActiveTM) in decreasing cry/fuss in infants aged 4 through 12 weeks with IC. The active group of infants will receive lactobacilli with vitamin D3 while the control group will receive vitamin D3 2 times daily as oil suspension for 28 days. Duration of infant fuss/cry will be measured at baseline and at the end of intervention to define a difference between the groups

NCT ID: NCT02727530 Completed - Infant Colic Clinical Trials

The Effectiveness of the Manual Therapy on Infant Colic (MT-IF)

Start date: April 2016
Phase: N/A
Study type: Interventional

The main goal of this study is to get to know if applying manual therapy will reduce the infant colic symptoms for to improve quality of life of babies and parents.

NCT ID: NCT01217658 Completed - Clinical trials for Postpartum Depression

Measuring and Reducing Excessive Infant Crying

UTHealth THB
Start date: January 2011
Phase: N/A
Study type: Interventional

Excessive infant crying (EIC) is likely to increase the risk of child abuse. The investigators propose a randomized trial using an intervention based on recommendations of Karp. The investigators will systematically identify 170 term infants with EIC and conduct assessments in the home at 6-8 weeks age to test the hypothesis that the intervention reduces mean infant hours of night-time crying, increases maternal soothing behaviors and improves parental anxiety and depression.

NCT ID: NCT00907621 Completed - Infant Colic Clinical Trials

Effects of Acupuncture in the Treatment of Infant Colic

Start date: September 2009
Phase: Phase 2
Study type: Interventional

Standardized acupuncture treatment for infant colic is a common treatment in general practice for doctors educated in medical acupuncture. The investigators plan to study whether the perceived opinion on positive results can be verified in a multi-center clinical trial. The investigators aim to measure the effect of standardized acupuncture treatment, three repeated sessions, on infant colic in a randomized singe blinded prospective multi-center study, starting September 2009. The study will be done in thirteen locations in Norway by specialists in General Practice trained in acupuncture. The investigators intend to include a total of 130 patients, 65 in the intervention group and 65 in the control group.